Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET

Journal of Nuclear Medicine

Volumn 44, Issue 10, 2003, Pages 1592-1598

  Yokoyama, Ikuo ^a   Inoue, Yusuke ^a   Moritan, Toshiyuki ^a   Ohtomo, Kuni ^a   Nagai, Ryozo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

18F FDG; Glucose utilization; Insulin resistance; PET; Skeletal muscle

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTERIAL BLOOD; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMUR; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKELETAL MUSCLE; ADULT; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HYPERINSULINISM; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; FEMUR; FLUORODEOXYGLUCOSE F18; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INSULIN RESISTANCE; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MUSCLE, SKELETAL; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0642280338     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. DeFronzo RA, Gunnarsson R, Bjorkman O, et al Effect of insulin on peripheral and splanchnic glucose metabolism in non-insulin dependent (type II) diabetes mellitus. J Clin Invest. 1985;76:149-155.
2. Steiner G, Morita S, Vranic M. Resistance to insulin but not to glucagon in lean human hypertriglyceridemics. Diabetes 1980;29:899-905
3. Reaven GM, Mejean L, Villaume C, Drouin P, Debry G. Plasma glucose and insulin responses to oral glucose in nonobese subjects and patients with endogenous hypertriglyceridemia. Metabolism 1983;32:447-450.
4. Yki-Jarvinen H, Taskinen MR Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia Diabetes. 1988;37:1271-1278
5. Nuutila P, Maki M, Laine H, et al. Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest. 1995;96:1003-1009.
6. Reaven GM Banting lecture 1988: role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
7. DeFronzo RA. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol. 1992;20(suppl 11):S1-S16.
8. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest 1990;85:1844-1852.
9. Roden M, Price TB, Perseghin G, et al. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996;97:2859-2865.
10. Boden G. Fatty acids and insulin resistance. Diabetes Care. 1996;19:394-395.
11. Nuutila P, Koivisto VA, Knuuti J, et al Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo J Clin Invest 1992;89:1767-1774.
12. Voipio-Pulkki LM, Nuutila P, Knuuti MJ, et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med. 1993;34:2064-2067.
13. 18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest 1996;97:1741-1747.
14. Paternostro G, Camici PG, Lammerstma AA, et al Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease, a study with positron emission tomography. J Clin Invest. 1996;98:2094-2099.
15. Kelley DE, Mintun MA, Watkins SC, et al. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest. 1996;97:2705-2713.
16. 18F]fluoro-2-deoxy-D- glucose, and positron emission tomography. Diabetes. 1996;45:1471-1477.
17. Yokoyama I, Ohtake T, Momomura S, et al. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension. J Nucl Med 1998;39:884-889.
18. Laine H, Yki-Jarvinen H, Kirvela O, et al Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 1998;101:1156-1162.
19. Ronnemaa EM, Ronnemaa T, Utriainen T, et al. Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers. Metabolism 1999;48:239-244
20. Yokoyama I, Yonekura K, Moritan T, et al Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients J Nucl Med. 2001;42:1005-1010.
21. Reinhardt M, Beu M, Vosberg H, et al. Quantification of glucose transport and phosphorylation in human, skeletal muscle using FDG PET. J Nucl Med 1999; 40:977-985.
22. Lackner R, Challiss RA, West D, Newsholme EA. A problem in the radiochemical assay of glucose-6-phosphatase in muscle. Biochem J. 1984;218:649-651.
23. Patlak CS, Blasberg RG, Fenstermacher JD Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data J Cereb Blood Flow Metab. 1983;3:1-7.
24. Weber WA, Schwaiger M, Avril N Quantitative assessment of tumor metabolism using FDG-PET imaging. Nucl Med Biol 2000;27:683-687.
25. 18F-FDG PET imaging of muscle activity in runners. J Nucl Med. 1999;40:70-76.
26. Tamaki N, Yonekura Y, Kawamoto M, et al. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition. J Nucl Med. 1991;32:2152-2157.
27. Nishikawa J, Ohtake T, Yokoyama I, Watanabe T, Momose T, Sasaki Y. Simple method to quantify myocardial glucose metabolism from MB ratio in myocardial FDG PET. Ann Nucl Med 1996;10:323-328
28. Ehrenkaufer RE, Potocki JF, Jewett DM. Simple synthesis of F-18-labeled 2-fluoro-2-deoxy-D-glucose: concise communication. J Nucl Med. 1984;25:333-337.
29. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization Diabetes. 1981;30:1000-1007.
30. Thie JA. Clarification of a fractional uptake concept [letter]. J Nucl Med 1995;36:711-712.
31. Choi Y, Brunken RC, Hawkins RA, et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993;20:308-318.